Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Issues in HIV/Hepatitis C Co-infection.

Jonathan P. Moorman1

  • 1Divisions of Infectious Diseases and Geographic Medicine, University of Virginia Health Sciences Center, Charlottesville, VA 22908, USA. jpm2x@virginia.edu

Current Infectious Disease Reports
|April 5, 2001
PubMed
Summary

Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection is common. This review discusses managing HCV in HIV patients on antiretroviral therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Chagas Disease: An Opportunistic Infection in AIDS.

Current infectious disease reports·2026
Same journal

Area-based Deprivation Indices and Healthcare-Associated Infections: A Narrative Review of Evidence.

Current infectious disease reports·2025
Same journal

Next Steps: Studying Diabetic Foot Infections with Next-Generation Molecular Assays.

Current infectious disease reports·2024
Same journal

To Tweet or Not to Tweet-a Review of the Viral Power of Twitter for Infectious Diseases.

Current infectious disease reports·2024
Same journal

Web alert.

Current infectious disease reports·2024
Same journal

Bacterial Vaginosis in Postmenopausal Women.

Current infectious disease reports·2023

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Virology

Background:

  • Co-infection with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) is prevalent.
  • HIV exacerbates HCV disease progression, raising long-term health concerns.
  • Increased patient longevity on highly active antiretroviral therapy (HAART) highlights the need for effective HCV management.

Purpose of the Study:

  • To review major issues concerning HIV/HCV co-infected patients.
  • To discuss current and evolving HCV therapies within the context of HAART.

Main Methods:

  • Literature review focusing on HIV/HCV co-infection.
  • Analysis of treatment strategies for HCV in HIV-positive individuals.
  • Discussion of challenges and advancements in managing co-infection.

Main Results:

  • HIV significantly impacts HCV disease course and outcomes.
  • Treatment paradigms for HCV are rapidly evolving.
  • Optimal HCV treatment strategies in HIV co-infected patients require further delineation.

Conclusions:

  • Effective management of HCV in HIV co-infected patients is crucial.
  • Antiretroviral therapy for HIV influences HCV treatment considerations.
  • Further research is needed to optimize combined treatment protocols.

Related Experiment Videos